LEADER 01743nam0-2200529---450-
001 990000085020203316
005 20000706
010   $a0-8493-8552-0
035   $a0008502
035   $aUSA010008502
035   $a(ALEPH)000008502USA01
035   $a0008502
100   $a20000706d1997----|||y0itay0103----ba
101 0 $aeng
102   $aUS
105   $aa---||||001yy
200 1 $aAntisense oligodeoxynucleotides and antisense RNA$enovel pharmacological and therapeutic agents$fedited by Benjamin Weiss
210   $aBoca Raton [etc.]$cCRC Press$dcopyr.1997
215   $a252 p.$cill.$d26 cm
225 2 $aPharmacology and toxicology$i: Basic and clinical aspects
410  0$a12001$aPharmacology and toxicology : Basic and clinical aspects
606   $aAcidi nucleici$xImpiego terapeutico
676   $a615.31
702  1$aWEISS,$bBenjamin
801   $aIT$bSALBC$gISBD
912   $a990000085020203316
951   $a615.31 ANT$b2066 Farm.$c615.31 ANT$d00000952
959   $aBK
979   $c20000914$lUSA01$h1739
979   $c20000919$lUSA01$h1048
979   $c20000919$lUSA01$h1521
979   $c20001019$lUSA01$h1056
979   $c20001019$lUSA01$h1454
979   $c20001019$lUSA01$h1501
979   $c20001019$lUSA01$h1539
979   $c20001024$lUSA01$h1515
979   $c20001027$lUSA01$h1519
979   $c20001027$lUSA01$h1523
979   $c20001110$lUSA01$h1710
979   $c20001124$lUSA01$h1208
979   $aPATTY$b90$c20010423$lUSA01$h1228
979   $c20020403$lUSA01$h1616
979   $aPATRY$b90$c20040406$lUSA01$h1607
979   $aPATRY$b90$c20121106$lUSA01$h1536
996   $aAntisense oligodeoxynucleotides and antisense RNA$91517305
997   $aUNISA
bas   $afar